Market Scope

Trusted Partner of Industry and Medical Professionals for Market Data, Independent Perspective, & Objective Analysis

Latest Reports Latest News

Market Scope Methodology

A Multi-Step Approach for Accurate & Timely Data

Proprietary data

  • 20+ years of physician survey data
  • Disease models
  • Cultivated database of physicians, ASCs, and hospitals
  • Insight from our team of in-house industry experts

Public data

  • Attendance and participation at major, worldwide meetings
  • Public health systems and registries
  • Clinical study data
  • Analysis of company-published financial reports

Physician Surveys

For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.

Complete a Survey

On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.

Benchmark Your Performance

Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.

View Market Insights & Analytics

Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.

Learn More Register Today

Latest Market Reports

Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.

Latest Industry News & Trends

UK Competition & Markets Authority Questions Stryker/Wright Merger

The United Kingdom Competition & Markets Authority (CMA) issued a statement of concern on June 30 regarding the Stryker and Wright Medical merger that is scheduled to take place later this year. Ba...

OphthalmicPress Release
COVID-19 Impact Varies Across China’s Ophthalmic Sectors

Renewed lockdown measures in parts of three northeastern provinces of China in mid-May underscore the difficulty in predicting how COVID-19 will affect daily life and business in China, including o...

LayerBio Gets $3 Million From US Pentagon to Advance Drug-Eluting OcuRing for IOL Haptic

LayerBio announced July 1 that it had received a $3 million Technology/Therapeutic Development Award from the US Department of Defense to develop its OcuRing drug delivery platform for cataract sur...

Santen, NTC Advance Post-Cataract Combination Eye Drop in Europe

Japan’s Santen and NTC, of Milan, Italy, announced June 29 the completion of the European decentralized procedure for marketing authorization of Ducressa, a fixed-dose combination of levofloxacin a...

Novartis Moves Away from Paying Physician Speakers, as it Settles Old Investigations

Novartis reported July 2 that it was moving away from the traditional speaker program model in the US, limiting the instances in which it pays external physicians to deliver education and eliminati...

SparingVision Gets EU Orphan Designation for RP Therapy

SparingVision announced June 30 that the European Commission granted orphan drug designation to its SPVN06 therapy for the treatment of retinitis pigmentosa (RP). The French company said the decisi...

Roche’s Enspryng Approved in Japan for Adults and Children with NMOSD

Swiss drugmaker Roche announced June 29 that Japan’s regulators had approved Enspryng (satralizumab) for the prevention of relapses of neuromyelitis optica spectrum disorder (NMOSD) in aquaporin-4 ...

Ocuphire Gains Nasdaq Listing in Rexahn Merger Deal

Privately held Ocuphire Pharma and Nasdaq-listed Rexahn Pharmaceuticals announced June 17 that they had agreed to merge in an all-stock transaction, with the combined entity taking the name Ocuphir...

Join Market Scope Today

Register A Corporate Account

A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.

Select one or more
Select one or more

Register A Clinical Account

A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.

US Surveys
May select more than one
Outside of US Surveys

Market Scope

13421 Manchester Road, Suite 201 | St. Louis, MO 63131 | Phone: 314-835-0600 | Email:

©2020 Market Scope, LLC. All Rights reserved.